Abstract
Edwardsiella tarda, a catalase-positive bacillus widely distributed throughout nature, is generally susceptible to trimethoprim/sulfamethoxazole. We describe osteomyelitis due to trimethoprim/sulfamethoxazole-resistant E. tarda in a patient with chronic granulomatous disease (CGD). Once E. tarda acquires antibiotic resistance, infected CGD patients may develop severe infections with unforeseeable consequences.
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / pharmacology*
-
Drug Resistance, Bacterial*
-
Edwardsiella tarda / drug effects
-
Edwardsiella tarda / isolation & purification*
-
Enterobacteriaceae Infections / diagnosis*
-
Enterobacteriaceae Infections / microbiology
-
Enterobacteriaceae Infections / pathology
-
Granulomatous Disease, Chronic / complications*
-
Humans
-
Infant, Newborn
-
Leg / diagnostic imaging
-
Leg / pathology
-
Magnetic Resonance Imaging
-
Male
-
Osteomyelitis / microbiology*
-
Osteomyelitis / pathology
-
Radiography
-
Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*
Substances
-
Anti-Bacterial Agents
-
Trimethoprim, Sulfamethoxazole Drug Combination